T2DM (TYPE 2 DIABETES MELLITUS)
Clinical trials for T2DM (TYPE 2 DIABETES MELLITUS) explained in plain language.
Never miss a new study
Get alerted when new T2DM (TYPE 2 DIABETES MELLITUS) trials appear
Sign up with your email to follow new studies for T2DM (TYPE 2 DIABETES MELLITUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New diabetes pill shows promise in Mid-Stage trial
Disease control OngoingThis study tests an experimental tablet called ASC30 in 100 adults with type 2 diabetes. The goal is to see if it safely lowers blood sugar and helps with weight over 13 weeks compared to a placebo. Participants must have stable weight and a BMI of 23 or higher.
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE2 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
Can online group visits help tame diabetes? new study aims to find out
Disease control OngoingThis study tests whether virtual group visits can help people with type 2 diabetes and related heart conditions better manage their blood sugar. About 720 adults with high A1C levels and at least one other cardiovascular risk factor will take part. The main goal is to see if thes…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
New study aims to spare bariatric patients from painful liver biopsies
Knowledge-focused OngoingThis study looks at 163 obese adults having weight-loss surgery to find better, needle-free ways to diagnose and track fatty liver disease (MASLD). Researchers will compare ultrasound-based tools and blood markers against standard liver biopsies. They also hope to identify biolog…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: Royal College of Surgeons in Ireland - Medical University of Bahrain • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:08 UTC